CNBC May 12, 2022
Spencer Kimball

Key Points

– The NIH has licensed its stabilized spike protein technology to the WHO, President Joe Biden said.

– The technology is key component of the current Covid-19 vaccines.

– The spike protein is the component in the vaccines that induces an immune response, prompting the body to fight the virus.

– The license would help the WHO work with manufacturers around the world to produce their own Covid-19 vaccines.

President Joe Biden on Thursday said the U.S. has licensed a key technology used in the current Covid-19 vaccines to the World Health Organization, which would allow manufacturers around the world to work with the global health agency to develop their own shots against the virus.

The National Institutes...

Today's Sponsors

Crossover Health

Today's Sponsors

Health Edge

Today's Sponsor


Topics: Biotechnology, Congress / White House, Govt Agencies, Healthcare System, Pharma / Biotech, Public Health / COVID
How technology can help providers fight back against the opioid epidemic
Reducing Child Food Insecurity After COVID-19: Policy Innovations And Cross-Sector Partnerships
Using digital innovation to prioritise patient safety during the pandemic
Long COVID is a new disability affecting millions of workers—and a ‘moment of essential innovation’ for employers, one lawyer contends
Industry innovation has shifted due to COVID-19